https://orcid.org/0000-0003-0941-8000
References
- Helsedirektoratet [Norwegian DIrectorate of Health]. Veileder for transfusjonstjenesten i Norge, utgave 7.3 [Guidelines for the Blood Transfusion Services in Norway, edition 7.3]. 75. Available from: https://www.helsedirektoratet.no/veiledere/transfusjonstjenesten-i-norge-utgave-73. Accessed December 27, 2022. Norwegian.
- Stainsby D, Brunskill S, Chapman CE, Dorée C, Stanworth S. Safety of blood donation from individuals with treated hypertension or non-insulin dependent type 2 diabetes – a systematic review. Vox Sang. 2010;98:431–440. doi:10.1111/j.1423-0410.2009.01275.x
- Thomas SHL, Weston Smith S, Slater NGP, Pearson TC, Treacher DF. The haemodynamic responses to venesection and the effects of cardiovascular disease. Clin lab Haematol. 1992;14:201–208. doi:10.1111/j.1365-2257.1992.tb00366.x
- Weisbach V, Schnabel L, Zimmermann R, Zingsem J, Eckstein R. A pilot study of continuous ambulatory monitoring of blood pressure in repeated preoperative autologous blood donation. Transfusion. 2006;46:934–941. doi:10.1111/j.1537-2995.2006.00825.x
- Pisciotto P, Sataro P, Blumberg N. Incidence of adverse reactions in blood donors taking antihypertensive medications. Transfusion. 1982;22(6):530–531. doi:10.1046/j.1537-2995.1982.22683068620.x
- Jurakić Tončić R, Marinović B, Lipozenčić J. Nonallergic hypersensitivity to nonsteroidal antiinflammatory drugs, angiotensin-converting enzyme inhibitors, radiocontrast media, local anesthetics, volume substitutes and medications used in general anesthesia. Acta Dermatovenerol Croat. 2009;17(1):54–69.
- Wiltbank TB, Giordano GF, Kamel H, Tomasulo P, Custer B. Faint and prefaint reactions in whole-blood donors: an analysis of predonation measurements and their predictive value. Transfusion. 2008;48:1799–1808. doi:10.1111/j.1537-2995.2008.01745.x
- Newman BH. Donor reactions and injuries from whole blood donation. Transfus Med Rev. 1997;11:64–75. doi:10.1016/S0887-7963(97)80011-9
- Almutairi H, Salam M, Alajlan A, Wani F, Al-Shammari B, Al-Surimi K. Incidence, predictors and severity of adverse events among whole blood donors. PLoS One. 2017;12(7):e0179831. doi:10.1371/journal.pone.0179831
- Nissen-Meyer LSH, Heier HE. Probability to be a blood donor in Oslo depending on geographical factors. Abstract, 35th International Congress of the ISBT, Toronto, Canada, June 2–6, 2018. Vox Sang. 2018;113(Suppl 1):5–347. doi:10.1111/vox.12658
- Klouman M, Åsberg A, Widerøe T-E. Blood pressure level in a Norwegian population – the significance of heritage and lifestyle. Tidsskr nor Laegeforen. 2011;131:1185–1189. doi:10.4045/tidsskr.10.0486
- Helsedirektoratet [Norwegian DIrectorate of Health]. Legemiddelbehandling av høyt blodtrykk [Pharmacologic antihypertensive therapy]. Available from: https://www.helsedirektoratet.no/retningslinjer/forebygging-av-hjerte-og-karsykdom/legemidler-ved-primaerforebygging-av-hjerte-og-karsykdom/legemiddelbehandling-av-hoyt-blodtrykk. Accessed December 27, 2022. Norwegian.
- Eder A, Goldman M, Rossmann S, Waxman D, Bianco C. Selection criteria to protect the blood donor in North America and Europe: past (dogma), present (evidence), and future (hemovigilance). Transfus Med Rev. 2009;23(3):205–220. doi:10.1016/j.tmrv.2009.03.003